Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1859807 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $1.04Day −14.75%Mkt cap $5M1Y −100.0%Off 52W high −100.0%Vol (1Y) 248.7%
Daily closing price, split-adjusted to the current basis; 1y shown of 252 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.1% of sh out |
| Days to cover1.0d |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-08 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$36.6M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−99.5% |
| 1Y−100.0% |
| Since incept. (ann.)−100.0% |
Total return through 2026-07-28 · series begins 2025-07-14. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)248.7% |
| Ann. volatility (3Y)310.3% |
| Sharpe (1Y)−2.35 |
| Sharpe (3Y)−1.53 |
| Max drawdown (1Y)−100.0% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)5.30 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 30,844 | $15,638 | 0.66% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 30,721 | $15,575 | 0.66% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,939 | $1,997 | 0.08% | new |
| Tower Research Capital LLC (TRC) | 1,791 | $908 | 0.04% | new |
| VANGUARD FIDUCIARY TRUST CO | 1,694 | $859 | 0.04% | new |
| MORGAN STANLEY | 1,600 | $811 | 0.03% | new |
| UBS Group AG | 665 | $337 | 0.01% | new |
| SBI Securities Co., Ltd. | 45 | $23 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | — | — | — | — |
| 2025-09-30 | 2025-11-19 | — | — | — | — |
| 2025-06-30 | 2025-08-14 | — | — | — | — |
| 2025-03-31 | 2025-06-13 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-08 is ESTIMATED from filing cadence (median gap 85d) — not company-confirmed.
